Severe moorens ulcer: Efficacy of monthly cyclophosphamide intravenous pulse treatment;Ulcères de mooren sévères: Efficacité du traitement par cyclophosphamide en bolus intraveineux mensuels

Revue de Medecine Interne

Volumn 24, Issue 2, 2003, Pages 118-122

  Tiev, K P ^a   Borderie, V M ^a   Briant, M ^a   Ziani, M ^a   Morvant, C ^a   Baret, M ^a   El Khattabi, A ^a   Genereau T ^a   Laroche, L ^a   Cabane, J ^a  

^a HÔPITAL SAINT ANTOINE   (France)

Author keywords

Adverse events; Cyclophosphamide; Moorens ulcer

Indexed keywords

CYCLOPHOSPHAMIDE; DEXAMETHASONE; METHYLPREDNISOLONE; NEOMYCIN; STEROID;

ADULT; AGED; ARTICLE; CASE REPORT; CORNEA PERFORATION; CORNEA RODENT ULCER; CORNEA TRANSPLANTATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG PULSE THERAPY; DRUG RESPONSE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; SIDE EFFECT; STEROID THERAPY; TREATMENT FAILURE; ULCER HEALING; VISION; VISUAL IMPAIRMENT;

ADULT; AGED; CORNEAL ULCER; CYCLOPHOSPHAMIDE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 0344089263     PISSN: 02488663     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0248-8663(02)00021-8     Document Type: Article

References (29)

1. Chow CYCC, Foster CS. Mooren's ulcer. Int Ophthalmol Clin 1996; 36:1-13.
2. Taylor CJ, Smith SI, Morgan CH, Stephenson SF, Key T, Srinivasan M, Cunningham E, Watson PG. HLA and Mooren's ulceration. Br J Ophthalmol 2000:84:72-5.
3. Voegtlé R, Borderie V, Baudrimont M, Touzeau O, Cabane J, Nordmann JP, Laroche L. L'ulcère de Mooren. J Fr Ophtalmol 2000;23: 711-7.
4. Brown SI, Mondino BJ. Therapy of Mooren's ulcer. Am J Ophthalmol 1984;98:1-6.
5. Watson PG. Management of Mooren's ulceration. Eye 1997;11: 349-56.
6. Wilson SE, Lee WM, Murakami C, Weng J, Moninger GA. Mooren- type hepatitis C virus-associated corneal ulceration. Ophthalmology 1994;101:736-45.
7. Moazami G, Auran JD, Florakis GJ, Wilson SE, Srinivasan DB. Interferon treatment of Mooren's ulcer associated with hepatitis C. Am J Ophthalmol 1995;1(19):365-6.
8. Haynes BF, Fisher ML, Fauci AS, Wolff SM. Ocular manifestations of Wegener's granulomatosis: fifteen years experience and review of the litterature. Am J Med 1977;63:131-41.
9. Gottsch JD, Liu SH, Minkovitz JB, Goodman DF, Srinivasan M, Stark WJ. Autoimmunity to a cornea-associated stromal antigen in patients with Mooren's ulcer. Invest Ophthalmol Vis Sci 1995;36: 1541-7.
10. Gottsch JD, Stark WJ, Liu SH. Cloning and sequence analysis of human and bovine corneal antigen cDNA: Identification of host-parasite protein Calgranulin C. Tr Am Ophthalmol Soc 1997;95: 111-29.
11. Van der Gaag R, Abdillahi H, Stilma JS, Vetter JCM. Circulating antibodies against corneal epithelium and hookworm in patients with Mooren's ulcer from Sierra Leone. Br J Ophthalmol 1983;67:623-8.
12. Berkowitz PJ, Arentsen JJ, Felberg NT, Laibson PR. Presence of circulating immune complexes in patients with peripheral corneal diseases. Arch Ophthalmol 1993;101:242-5.
13. Lopez JS, Price FW, Whitcup SM, Li Q, De Smet M, Chan CC. Immunohistochemistry of Terrien's and Mooren's corneal degeneration. Arch Ophthalmol 1991;109:988-91.
14. Foster CS. Immunosuppresive therapy for external occular inflammatory disease. Ophthalmology 1980;87:140-50.
15. Tauber J, Sainz de la Maza M, Hoang-Xuan T, Foster CS. An analysis of therapeutic decision making regarding immunosuppressive chemotherapy for peripheral ulcerative keratitis. Cornea 1990;1:66-73.
16. Genvert G, Sakauye CM, Arentsen JJ. Treatment of marginal corneal ulcers with cryotherapy and conjonctival recession or resection. Cornea 1985;3:256-61.
17. Aviel E. Combined cryoapplications and peritomy in Mooren's ulcer. Br J Ophthalmol 1972:48-51.
18. Stilma JS. Conjonctival excision lamellar scleral autograft in 38 Mooren's ulcer from Sierra Leone. Br J Ophthalmol 1983;67:475-8.
19. Brown SI. Mooren's ulcer treatment by conjonctival excision. Br J Ophthalmol 1975;59:675-82.
20. Chihara E, Nishi R, Asayama K, Tsukahara I. Treatment of Mooren's ulcer by conjonctival excision. Ophthalmologica 1979;179:258-64.
21. Bodaghi B, Levy C, Votan P, Hoang-Xuan T. Intérêt des colles cyanoacrylates dans les ulcères périphériques d'origine inflammatoire. J Fr Ophtalmol 1996;19:127-32.
22. Brown SI, Mondino BJ. Penetrating keratoplsty in Mooren's ulcer. Am J Ophthalmol 1980;89:255-8.
23. Martin NF, Stark WJ, Maumenee AE. Treatment of Mooren's and Mooren's-like ulcer by lamellar keratectomy: report of six eyes and literature review. Ophthalmic Surg 1987;18:564-9.
24. Kinoshita S, Ohashi Y, Ohji M, Manabe R. Long-term results of keratoepithelioplasty in Mooren's ulcer. Ophthalmology 1991;98: 438-45.
25. Bessant DAR, Dart JKG. Lamelar keratoplasty in the management of inflammatory corneal ulceration and perforation. Eye 1994;8:22-8.
26. Hill JC, Potter P. Treatment of Mooren's ulcer with cyclosporin A: report of three cases. Br J Ophthalmol 1987;71:11-5.
27. Zhao JC, Jin XY. Immunological analysis and treatment of Mooren's Ulcer with cyclosporin A applied topically. Cornea 1993;12:481-8.
28. Foster CS. Systemic immunosuppressive therapy for progressive bilateral Mooren's ulcer. Ophthalmology 1985;92:1436-9.
29. Guillevin L, Cordier JF, Lhote F, Cohen P, Jarrousse B, Royer I, et al. A prospective, multicenter, randomized trial comparing steroids and pulse Cyclophosphamide versus steroids and oral Cyclophophamide in the treatment of generalized Wegener's granulomatosis. Arthritis Rheum 1997;40:2187-98.